Logo image of 1EXPE.MI

EXPEDIA GROUP INC (1EXPE.MI) Stock Fundamental Analysis

BIT:1EXPE - Euronext Milan - US30212P3038 - Common Stock - Currency: EUR

188.4  -9.28 (-4.69%)

Fundamental Rating

5

1EXPE gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 55 industry peers in the Hotels, Restaurants & Leisure industry. 1EXPE scores excellent on profitability, but there are concerns on its financial health. 1EXPE has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year 1EXPE was profitable.
In the past year 1EXPE had a positive cash flow from operations.
In multiple years 1EXPE reported negative net income over the last 5 years.
Of the past 5 years 1EXPE 4 years had a positive operating cash flow.
1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCF1EXPE.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

1.2 Ratios

With a decent Return On Assets value of 5.49%, 1EXPE is doing good in the industry, outperforming 68.00% of the companies in the same industry.
With an excellent Return On Equity value of 78.87%, 1EXPE belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
1EXPE has a Return On Invested Capital of 13.93%. This is in the better half of the industry: 1EXPE outperforms 76.00% of its industry peers.
1EXPE had an Average Return On Invested Capital over the past 3 years of 10.99%. This is in line with the industry average of 11.55%.
The 3 year average ROIC (10.99%) for 1EXPE is below the current ROIC(13.93%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROIC 13.93%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
1EXPE.MI Yearly ROA, ROE, ROIC1EXPE.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

With a decent Profit Margin value of 8.97%, 1EXPE is doing good in the industry, outperforming 64.00% of the companies in the same industry.
In the last couple of years the Profit Margin of 1EXPE has grown nicely.
The Operating Margin of 1EXPE (12.15%) is comparable to the rest of the industry.
1EXPE's Operating Margin has improved in the last couple of years.
1EXPE has a Gross Margin of 89.44%. This is amongst the best in the industry. 1EXPE outperforms 88.00% of its industry peers.
1EXPE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
1EXPE.MI Yearly Profit, Operating, Gross Margins1EXPE.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

3

2. Health

2.1 Basic Checks

1EXPE has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for 1EXPE has been reduced compared to 1 year ago.
Compared to 5 years ago, 1EXPE has less shares outstanding
Compared to 1 year ago, 1EXPE has an improved debt to assets ratio.
1EXPE.MI Yearly Shares Outstanding1EXPE.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
1EXPE.MI Yearly Total Debt VS Total Assets1EXPE.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

1EXPE has an Altman-Z score of 1.44. This is a bad value and indicates that 1EXPE is not financially healthy and even has some risk of bankruptcy.
1EXPE's Altman-Z score of 1.44 is in line compared to the rest of the industry. 1EXPE outperforms 44.00% of its industry peers.
1EXPE has a debt to FCF ratio of 2.69. This is a good value and a sign of high solvency as 1EXPE would need 2.69 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.69, 1EXPE is doing good in the industry, outperforming 76.00% of the companies in the same industry.
A Debt/Equity ratio of 3.35 is on the high side and indicates that 1EXPE has dependencies on debt financing.
1EXPE has a Debt to Equity ratio of 3.35. This is in the lower half of the industry: 1EXPE underperforms 68.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Altman-Z 1.44
ROIC/WACC1.6
WACC8.73%
1EXPE.MI Yearly LT Debt VS Equity VS FCF1EXPE.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B -4B 6B 8B

2.3 Liquidity

A Current Ratio of 0.72 indicates that 1EXPE may have some problems paying its short term obligations.
1EXPE's Current ratio of 0.72 is on the low side compared to the rest of the industry. 1EXPE is outperformed by 72.00% of its industry peers.
A Quick Ratio of 0.72 indicates that 1EXPE may have some problems paying its short term obligations.
1EXPE has a Quick ratio of 0.72. This is in the lower half of the industry: 1EXPE underperforms 66.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.72
Quick Ratio 0.72
1EXPE.MI Yearly Current Assets VS Current Liabilites1EXPE.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

1EXPE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.64%, which is quite impressive.
The Earnings Per Share has been growing by 14.87% on average over the past years. This is quite good.
The Revenue has been growing slightly by 6.64% in the past year.
1EXPE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.56% yearly.
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%

3.2 Future

1EXPE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.48% yearly.
The Revenue is expected to grow by 6.21% on average over the next years.
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y10.48%
Revenue Next Year6.62%
Revenue Next 2Y6.87%
Revenue Next 3Y7.07%
Revenue Next 5Y6.21%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
1EXPE.MI Yearly Revenue VS Estimates1EXPE.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1EXPE.MI Yearly EPS VS Estimates1EXPE.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 10 20 30

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.10 indicates a correct valuation of 1EXPE.
72.00% of the companies in the same industry are more expensive than 1EXPE, based on the Price/Earnings ratio.
1EXPE is valuated rather cheaply when we compare the Price/Earnings ratio to 29.35, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 13.54, the valuation of 1EXPE can be described as correct.
1EXPE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. 1EXPE is cheaper than 70.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.10, 1EXPE is valued a bit cheaper.
Industry RankSector Rank
PE 16.1
Fwd PE 13.54
1EXPE.MI Price Earnings VS Forward Price Earnings1EXPE.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

1EXPE's Enterprise Value to EBITDA is on the same level as the industry average.
1EXPE's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. 1EXPE is cheaper than 74.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 10.91
EV/EBITDA 11.02
1EXPE.MI Per share data1EXPE.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of 1EXPE may justify a higher PE ratio.
A more expensive valuation may be justified as 1EXPE's earnings are expected to grow with 17.50% in the coming years.
PEG (NY)0.85
PEG (5Y)1.08
EPS Next 2Y18.99%
EPS Next 3Y17.5%

2

5. Dividend

5.1 Amount

1EXPE has a yearly dividend return of 0.78%, which is pretty low.
1EXPE's Dividend Yield is a higher than the industry average which is at 2.93.
With a Dividend Yield of 0.78, 1EXPE pays less dividend than the S&P500 average, which is at 2.33.
Industry RankSector Rank
Dividend Yield 0.78%

5.2 History

Dividend Growth(5Y)N/A
Div Incr YearsN/A
Div Non Decr YearsN/A

5.3 Sustainability

DP0%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
1EXPE.MI Yearly Income VS Free CF VS Dividend1EXPE.MI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B -4B

EXPEDIA GROUP INC

BIT:1EXPE (3/3/2025, 7:00:00 PM)

188.4

-9.28 (-4.69%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-06 2025-02-06/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners97.28%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap24.28B
Analysts71.16
Price Target190.25 (0.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.78%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.08%
Min EPS beat(2)-0.95%
Max EPS beat(2)15.12%
EPS beat(4)3
Avg EPS beat(4)53.42%
Min EPS beat(4)-0.95%
Max EPS beat(4)187.08%
EPS beat(8)6
Avg EPS beat(8)-17.83%
EPS beat(12)8
Avg EPS beat(12)-10.27%
EPS beat(16)11
Avg EPS beat(16)-1.1%
Revenue beat(2)1
Avg Revenue beat(2)-0.78%
Min Revenue beat(2)-3.22%
Max Revenue beat(2)1.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-3.22%
Max Revenue beat(4)1.66%
Revenue beat(8)2
Avg Revenue beat(8)-0.98%
Revenue beat(12)3
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)0.33%
PT rev (1m)8.11%
PT rev (3m)23.24%
EPS NQ rev (1m)118.58%
EPS NQ rev (3m)659.09%
EPS NY rev (1m)1.29%
EPS NY rev (3m)-7.29%
Revenue NQ rev (1m)-2.25%
Revenue NQ rev (3m)-1.28%
Revenue NY rev (1m)-1.14%
Revenue NY rev (3m)-5.13%
Valuation
Industry RankSector Rank
PE 16.1
Fwd PE 13.54
P/S 1.86
P/FCF 10.91
P/OCF 8.24
P/B 16.32
P/tB N/A
EV/EBITDA 11.02
EPS(TTM)11.7
EY6.21%
EPS(NY)13.91
Fwd EY7.38%
FCF(TTM)17.27
FCFY9.17%
OCF(TTM)22.88
OCFY12.14%
SpS101.53
BVpS11.55
TBVpS-45.26
PEG (NY)0.85
PEG (5Y)1.08
Profitability
Industry RankSector Rank
ROA 5.49%
ROE 78.87%
ROCE 18.96%
ROIC 13.93%
ROICexc 28.48%
ROICexgc N/A
OM 12.15%
PM (TTM) 8.97%
GM 89.44%
FCFM 17.01%
ROA(3y)3.61%
ROA(5y)-0.96%
ROE(3y)48.88%
ROE(5y)5.49%
ROIC(3y)10.99%
ROIC(5y)N/A
ROICexc(3y)20.29%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.96%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y125.83%
ROICexc growth 5Y22.57%
OM growth 3Y58.59%
OM growth 5Y8.82%
PM growth 3YN/A
PM growth 5Y14%
GM growth 3Y2.82%
GM growth 5Y1.74%
F-Score8
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 3.35
Debt/FCF 2.69
Debt/EBITDA 2.09
Cap/Depr 90.21%
Cap/Sales 5.52%
Interest Coverage 7.2
Cash Conversion 123.3%
Profit Quality 189.66%
Current Ratio 0.72
Quick Ratio 0.72
Altman-Z 1.44
F-Score8
WACC8.73%
ROIC/WACC1.6
Cap/Depr(3y)92.88%
Cap/Depr(5y)87.19%
Cap/Sales(3y)5.93%
Cap/Sales(5y)8.19%
Profit Quality(3y)403.1%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)24.64%
EPS 3Y104.08%
EPS 5Y14.87%
EPS Q2Q%38.95%
EPS Next Y18.93%
EPS Next 2Y18.99%
EPS Next 3Y17.5%
EPS Next 5Y10.48%
Revenue 1Y (TTM)6.64%
Revenue growth 3Y16.77%
Revenue growth 5Y2.56%
Sales Q2Q%10.29%
Revenue Next Year6.62%
Revenue Next 2Y6.87%
Revenue Next 3Y7.07%
Revenue Next 5Y6.21%
EBIT growth 1Y13.43%
EBIT growth 3Y85.19%
EBIT growth 5Y11.61%
EBIT Next Year133.26%
EBIT Next 3Y40.4%
EBIT Next 5Y26.15%
FCF growth 1Y26.3%
FCF growth 3Y-8.85%
FCF growth 5Y7.7%
OCF growth 1Y14.68%
OCF growth 3Y-6.28%
OCF growth 5Y2.2%